PubMed COVID-19 Clinical Care

CONCLUSION: T-cell populations and CD8 subset help to differentiate the mild and severe COVID-19 patients. Monitoring T cells, especially CD8 subset changes, has important implications for diagnosing and treating mild and severe patients being

The COVID-19 pandemic led to the delay of colorectal cancer (CRC) diagnosis, which causes CRC to be treated at more advanced, often metastatic stages. Unfortunately, there is no effective treatment for metastatic CRC stages, which are considered the

CONCLUSIONS: The prevalence of subclinical hypothyroidism among COVID-19 patients was found to be similar to other studies done in similar settings.

Background The evaluation of the effectiveness of the vaccines (ChAdOx1-nCOV; Covishield and BBV-152; Covaxin) against coronavirus disease 2019 (COVID-19) is necessary to assess their efficacy. Because most antibodies that neutralize the coronavirus

No abstract

CONCLUSION: Based on student and instructor perspectives, vOSCEs could be a viable alternative to in-person OSCEs for health history evaluations. As technology applications continue to emerge for conducting virtual examinations, there may be

This qualitative study included in-depth semistructured interviews with 17 social workers from across the state of Texas that took place during the summer of 2021. The purpose of this study was to describe social workers' experiences of workplace

INTRODUCTION: Aircraft noise is one of the most significant sources of environmental pollution in large cities. During the COVID-19 pandemic, strict lockdown in community might increase residents' discomfort with the noise, which could disrupt public

CONCLUSION: Our investigation showed a low level of knowledge about self-medication and a considerable level of self-medication practices. Therefore, self-medication may be minimized with ongoing awareness-raising and sensitization.

INTRODUCTION: Poor adherence to antipsychotic medication is common in the treatment of schizophrenia and other psychotic disorders. Paliperidone palmitate 3-monthly (PP3M) is the first long-acting injectable (LAI) antipsychotic to allow for only four